We’re putting the EMPHASIS back on CELIAC DISEASE .

A conversation about celiac disease and COVID-19 with Beyond Celiac and Diana Rocco

This April and May, Beyond Celiac has joined forces with Sjögren's Foundation to spread awareness about Sjögren's and celiac disease during our respective awareness months.

Beyond Celiac has launched The Voices of Celiac Disease, a story-collection initiative aimed at spreading awareness and understanding of celiac disease by highlighting diverse personal stories.

A new approach to treating celiac disease by using nanoparticles to program the immune system to tolerate gluten showed promise in early results, according to a newly published study.

Recent data from the Go Beyond Celiac Gluten Exposure Survey highlights a number of neurological and psychological symptoms that celiac disease patients report experiencing after exposure to gluten, adding to the call that patients truly experience more than just GI troubles.  

ACeD Study launched second part of clinical trial last month

Even people with celiac disease who seem to be doing well on a gluten-free diet may have on-going, low-level intestinal inflammation, according to a new study that looked at complete protein profiles in biopsy samples.

People with celiac disease don’t have an increased risk of developing severe COVID-19, a new study has found. The study results align with earlier conclusions about celac disease and COVID-19 risk.

Foods for when you suffer from both celiac disease and diverticulitis

Monitoring celiac disease

How to tell if ongoing symptoms are from celiac disease

What’s the point of follow-up testing and monitoring?

Are gluten-free and wheat-free the same?

Celiac disease community is an integral part of research into this potential immune tolerance treatment

Recruitment of symptomatic participants in the first celiac disease Phase 3 clinical trial continues

New potential treatment for celiac disease aims to re-educate the immune system so it does not react to gluten

Celiac disease study postponed due to COVID-19 is relaunching in November

A trial that launched in late August will test PRV-015 in symptomatic celiac disease patients